Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001017491-14-000096)

Filing Details

Accession Number:: 0001017491-14-000096
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-24 14:41:59
Reporting Period:: 2014-10-22

Filing Date:: 2014-10-24
Accepted Time:: 2014-10-24 14:41:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1017491	Apricus Biosciences Inc.	APRI	Pharmaceutical Preparations (2834)	870449967

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1235945	Wendall Wierenga	11975 El Camino Real, Suite 300 San Diego CA 92130		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-10-22	20,000	$1.52	20,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.